Want to see DARE full AI Analyst Report?
Lopinavir / Ritonavir
Human Papilloma Virus (Hpv), High-Risk Human Papillomavirus Infection
Phase II
Not Yet Recruiting
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
May 15, 2026
―
Vehicle, Sildenafil
Sexual Arousal Disorder
Phase I
Completed
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
Mar 01, 2023
―
Diclofenac 1%, Diclofenac 3%
Dysmenorrhea Primary
Phase I
Completed
A Study of Diclofenac Gel in Women With Primary Dysmenorrhea
Feb 21, 2023
―
Ivr Dose 1, Ivr Dose 2
Vulvovaginal Atrophy, Vasomotor Symptoms
Phase I/II
Completed
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
May 02, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Daré Bioscience Inc (DARE) have in its pipeline
DARE is currently developing the following drugs: Lopinavir / Ritonavir, Progesterone, Vehicle, Sildenafil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.